CN Patent

CN104530016A — 一种雷迪帕韦的制备方法及其中间体

Assigned to PHARMARESOURCES (SHANGHAI) CO Ltd · Expires 2015-04-22 · 11y expired

What this patent protects

本发明涉及丙型肝炎药物雷迪帕韦(I)的一种新制备方法以及在该制备方法中使用的新中间体。

USPTO Abstract

本发明涉及丙型肝炎药物雷迪帕韦(I)的一种新制备方法以及在该制备方法中使用的新中间体。

Drugs covered by this patent

Patent Metadata

Patent number: CN104530016A
Jurisdiction: CN
Classification: —
Expires: 2015-04-22
Drug substance claim: No
Drug product claim: No
Assignee: PHARMARESOURCES (SHANGHAI) CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.